Donohue Mark
Known title: Chief Financial OfficerCIK: 0001930278
Associated companies
Transaction History
| EVLV | ▼ Sell | Open Market | 186,483 | $509K | 6/3/2024 | View on chart |
| EVLV | ▲ Buy | Option Exercise | 366,936 | $0 | 6/1/2024 | View on chart |
| EVLV | ▼ Sell | Open Market | 39,323 | $143K | 3/4/2024 | View on chart |
| EVLV | ▲ Buy | Option Exercise | 117,509 | $0 | 3/1/2024 | View on chart |
| EVLV | ▼ Sell | Open Market | 368 | $2K | 1/3/2024 | View on chart |
| EVLV | ▲ Buy | Option Exercise | 1,000 | $0 | 1/1/2024 | View on chart |
| EVLV | ▼ Sell | Open Market | 158,991 | $929K | 6/2/2023 | View on chart |
| EVLV | ▲ Buy | Option Exercise | 366,935 | $0 | 6/1/2023 | View on chart |
| EVLV | ▼ Sell | Open Market | 388 | $920 | 1/5/2023 | View on chart |
| EVLV | ▲ Buy | Grant | 1,000 | $0 | 1/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
EVLV: Analysts Highlight Overlooked Growth Potential
Recent commentary suggests Evolv Technologies may be undervalued, with analysts pointing to growth factors that the market is currently ignoring. This perspective contrasts with the stock's recent weakness, as it trades near its 52-week low and shows high beta volatility. The average analyst target remains significantly higher than the current price, indicating a potential gap between market sentiment and fundamental expectations.
EVLV: Analysts Highlight Overlooked Growth Potential. Recent commentary suggests Evolv Technologies may be undervalued, with analysts pointing to growth factors that the market is currently ignoring. This perspective contrasts with the stock's recent weakness, as it trades near its 52-week low and shows high beta volatility. The average analyst target remains significantly higher than the current price, indicating a potential gap between market sentiment and fundamental expectations.